The divergent opinions of regulatory authorities on roflumilast are puzzling but we need new drugs for treating chronic obstructive pulmonary disease.
作者信息
Cazzola Mario
出版信息
Ther Adv Respir Dis. 2010 Aug;4(4):195-8. doi: 10.1177/1753465810377636.
PMID:20696819
Abstract
摘要
相似文献
1
The divergent opinions of regulatory authorities on roflumilast are puzzling but we need new drugs for treating chronic obstructive pulmonary disease.
Ther Adv Respir Dis. 2010 Aug;4(4):195-8. doi: 10.1177/1753465810377636.
2
[Roflumilast: a new approach to therapy of chronic obstructive pulmonary disease].
Med Monatsschr Pharm. 2010 Jul;33(7):236-43.
3
Reduce disease burden and improve lung function-roflumilast: approved for moderate to severe COPD: update for the clinical nurse specialist.
Clin Nurse Spec. 2011 Jul-Aug;25(4):176-7. doi: 10.1097/NUR.0b013e31822229a9.
4
Roflumilast for chronic obstructive pulmonary disease.
Lancet. 2005 Nov 26;366(9500):1845-6; author reply 1846-7. doi: 10.1016/S0140-6736(05)67748-3.
5
Roflumilast (Daliresp) for COPD.
Med Lett Drugs Ther. 2011 Jul 25;53(1369):59-60.
6
Roflumilast for the treatment of chronic obstructive pulmonary disease.
Expert Rev Respir Med. 2010 Oct;4(5):543-55. doi: 10.1586/ers.10.56.
7
The potential role of roflumilast: the new phosphodiesterase-4 inhibitor.
Ann Pharmacother. 2006 Jun;40(6):1096-104. doi: 10.1345/aph.1E651. Epub 2006 May 30.
8
The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
Pulm Pharmacol Ther. 2010 Aug;23(4):235-56. doi: 10.1016/j.pupt.2010.03.011. Epub 2010 Apr 7.
9
Roflumilast for severe COPD?
Drug Ther Bull. 2011 Apr;49(4):45-8; quiz iii-iv. doi: 10.1136/dtb.2011.02.0025.
10
Roflumilast for asthma and chronic obstructive pulmonary disease.
Issues Emerg Health Technol. 2005 Oct(74):1-4.
Zotero 插件